Filing Flows › Axogen (AXGN) › Q3 2026 › vs Q2 2026
Axogen (AXGN) Q3 2026 vs Q2 2026 (quarter over quarter)
Axogen's revenue rose $6.1M (+9%) from $69.7M in Q2 2026 to $75.8M in Q3 2026. Gross margin 74.8% against 72.7% (+2.1 pts).
Axogen, Q3 2026: revenue $75.8M (+26% year over year), operating margin 1.3%, net earnings $2.3M, operating cash flow $16.5M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 74.8% | 72.7% | +2.1 pts |
| Operating margin | 1.3% | -3.1% | +4.4 pts |
| Net margin | 3.1% | -2.2% | +5.3 pts |
| Free cash flow margin | 20.0% | 9.1% | +10.9 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $75.8M | $69.7M | $6.1M | +9% |
| Gross profit | $56.7M | $50.7M | $6.1M | +12% |
| Cost of revenue | $19.1M | $19.1M | $46K | +0.2% |
| Other income, net | $1.4M | $640K | $739K | +115% |
| Operating profit | $955K | −$2.2M | $3.1M | — |
| Operating expenses | $55.8M | $52.8M | $2.9M | +6% |
| Pre-tax earnings | $2.3M | −$1.5M | $3.9M | — |
| Research & development | $8.9M | $8.6M | $361K | +4% |
| Sales & marketing | $30.4M | $30.8M | −$466K | -2% |
| General & admin | $16.5M | $13.4M | $3.1M | +23% |
| Net earnings | $2.3M | −$1.5M | $3.9M | — |
| Depreciation & amortization | $1.7M | $1.7M | −$24K | -1% |
| Share-based compensation | $8.8M | $8.8M | $28K | +0.3% |
| Working capital & other | $3.7M | −$1.7M | $5.5M | — |
| Operating cash flow | $16.5M | $7.2M | $9.3M | +129% |
| Free cash flow (OCF − capex) | $15.1M | $6.3M | $8.8M | +139% |
| Capital expenditures | $1.4M | $893K | $499K | +56% |
Questions
How much did Axogen's revenue grow quarter over quarter in Q3 2026?
Axogen's revenue rose $6.1M (+9%) from $69.7M in Q2 2026 to $75.8M in Q3 2026. Gross margin 74.8% against 72.7% (+2.1 pts).